- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07761143
Impact of Device Free Summer Camp on Adolescent Mental Health and Wellbeing
IMPACT OF DEVICE FREE SUMMER CAMP ON ADOLESCENT MENTAL HEALTH AND WELLBEING
The goal of this clinical trial is to understand if attendance of a device-free summer camp, representing a shift from a digital environment to one that is device free and involves in person social interaction, can change mental health status and brain physiology in teens age 12-17. The main question it aims to answer is:
- How much is aggregate mental health and its various dimensions and components changed at the end of the camp attendance relative to the start of camp.
- How much is brain physiology, as measured by EEG change, changed at the end of camp relative to the start of camp.
Participants are recruited from among teens signed up to attend 2 or 3.5 week sessions a summer camp in Maine.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
The goal of this clinical trial is to understand if attendance of a device-free summer camp, representing a shift from a digital environment to one that is device free and involves in person social interaction, can change mental health status and brain physiology in teens age 12-17. The main question it aims to answer is:
- How much is aggregate mental health and its various dimensions and components changed at the end of the camp attendance relative to the start of camp.
- How much is brain physiology, as measured by EEG change, changed at the end of camp relative to the start of camp.
Participants are recruited from among teens signed up to attend 2 or 3.5 week sessions a summer camp in Maine. Participants were asked to complete the MHQ, a comprehensive mental health assessment spanning 47 emotional, social and cognitive aspects and on the first day of camp and then again on the day before departure. In addition participants were asked questions on their school and camp experiences at the start and end of camp respectively.
Participants were also invited to participate in a socio-emotional task and/or have EEG measurements read on the first day of camp and the day before departure form camp. The socio-emotional task involved speaking or performing in front of a group of 4 or 5 people and rating one's own feelings performing this task as well as rating the perceived feelings of other group members when they were performing the task.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Maine
-
Porter, Maine, Verenigde Staten, 04068
- Maine Teen Camp
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Kind
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Attendance of Maine Teen Camp sessions during summer months of 2024 and 2025.
Exclusion Criteria:
- None
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Preventie
- Toewijzing: NVT
- Interventioneel model: Opdracht voor een enkele groep
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Maine Teen Camp attendees
Attendance of a residential device-free summer camp for teens for 2 to 3.5 weeks characterized by in-person interaction and nature rich outdoor activities.
|
Attendance of a residential device-free summer camp in Maine for 2-3.5 weeks.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change from Baseline in Mental Health Quotient (MHQ) at End of Camp
Tijdsspanne: Baseline (Day 1) to end of camp attendance (up to 3.5 weeks).
|
The Mental Health Quotient or MHQ is an aggregate score of mental health computed from the 47 items of the MHQ assessment.
The score ranges from -100 to +200, where higher scores indicate better mental health outcomes.
Negative scores indicate significant symptoms that impact function (Distressed/Struggling range), while positive scores reflect the wide range of normal function (Enduring to Thriving).
Change is calculated by subtracting the baseline score from the end of camp score.
|
Baseline (Day 1) to end of camp attendance (up to 3.5 weeks).
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change from Baseline in Ratings of 47 MHQ Items After Camp Attendance
Tijdsspanne: Baseline (Day 1) to end of camp attendance (up to 3.5 weeks).
|
Difference in the ratings of each of the 47 items in the MHQ assessment spanning emotional, social, cognitive and physical capacities and problems.
Participants rate each item on a 9-point life impact scale.
|
Baseline (Day 1) to end of camp attendance (up to 3.5 weeks).
|
|
Change from Baseline in Resting-State Electroencephalography (EEG) measures
Tijdsspanne: Baseline (Day 1 of camp) and Post-Intervention (Final day of camp - 2.5-3 weeks later)
|
The outcome measure evaluates changes in EEG spectral metrics such as spectral slope, spectral bands and time domain metrics such as complexity/entropy measures such as Detrending Fluctuation Analysis (DFA), Lempel-Ziv Complexity and Sample Entropy measured during 3 minutes of EEG with eyes closed at the start and end of the camp session.
|
Baseline (Day 1 of camp) and Post-Intervention (Final day of camp - 2.5-3 weeks later)
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: Tara Thiagarajan, PhD, Sapien Labs
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- MTC_24_25
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
IPD-tijdsbestek voor delen
IPD-toegangscriteria voor delen
IPD delen Ondersteunend informatietype
- LEERPROTOCOOL
- ICF
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .